🇺🇸 PFE — Pfizer Inc.

Healthcare Compra
← Volver

Precio actual

27,79 USD

Máx. histórico

61,71

1723 días

Split 1054:1000 del 17/11/2020

Caída desde máximo

-54,97%

Rango 52 semanas

23,58 – 29,21

Variación hoy

-2,32%

Cierre anterior

28,45

Rango de hoy

27,72 – 28,15

Volumen hoy

31.727.745

Información
Nombre completo
Pfizer Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
75.000
PER
36,57 (puede no estar actualizado)
Dividend yield
6,05% (puede no estar actualizado)
Precio objetivo analistas
28,61 USD (puede no estar actualizado)
Primera cotización
01/06/1972
Precio actualizado
hace 3 horas
Sobre la empresa

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic areas comprising amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, and Hympavzi brands; and anti-infective and immunoglobulin medicines under the Zavicefta, Octagam, and Panzyga brands. In addition, the company offers oncology products comprising ADCs, small molecules, bispecific, and other immunotherapies for the treatment of cancers, including breast cancer, genitourinary cancer, and hematologic malignancies, as well as melanoma, gastrointestinal, gynecological, and lung cancer under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. Further, it provides biosimilars under the Inflectra brand; oncology biosimilars comprising Retacrit, Ruxience, Zirabev, Trazimera and Nivestym, and other biosimilars; and sterile injectables, such as Sulperazon, Atgam, Fragmin, Solu Medrol, Solu Cortef, and Bicillin. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as a strategic collaboration with Boltz, PBC to develop and deploy biomolecular AI foundation models. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Dividendos repartidos Total últimos 12 meses: 1,7200 USD · Yield: 6,19%
Fecha de pago Importe por participación
06/05/2015 0,2657 USD
04/02/2015 0,2657 USD
05/11/2014 0,2467 USD
30/07/2014 0,2467 USD
07/05/2014 0,2467 USD
05/02/2014 0,2467 USD
06/11/2013 0,2277 USD
31/07/2013 0,2277 USD
08/05/2013 0,2277 USD
30/01/2013 0,2277 USD
07/11/2012 0,2087 USD
01/08/2012 0,2087 USD
09/05/2012 0,2087 USD
01/02/2012 0,2087 USD
08/11/2011 0,1898 USD
Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2020 1054:1000
01/07/1999 3:1
01/07/1997 2:1
03/07/1995 2:1
01/04/1991 2:1
01/07/1983 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
15/11/2001 40,37 40,75 40,02 40,46 +0,64% 1,81% 10.140.956
14/11/2001 40,39 40,52 40,03 40,21 -0,47% 1,22% 10.636.019
13/11/2001 40,04 40,40 39,78 40,40 +1,24% 1,54% 11.169.976
12/11/2001 39,97 40,25 39,49 39,91 -0,17% 1,90% 7.482.662
09/11/2001 40,13 40,31 39,59 39,97 -0,40% 1,80% 8.527.071
08/11/2001 40,22 40,41 39,86 40,13 +0,38% 1,37% 10.346.486
07/11/2001 39,92 40,46 39,91 39,98 -0,40% 1,38% 11.923.797
06/11/2001 39,75 40,30 39,32 40,14 +0,83% 2,48% 11.948.355
05/11/2001 40,37 40,69 39,66 39,81 -0,57% 2,56% 11.647.543
02/11/2001 40,55 40,61 39,91 40,04 -1,26% 1,71% 10.996.277
01/11/2001 39,85 40,56 39,75 40,55 +2,00% 2,02% 13.237.924
31/10/2001 40,23 40,31 39,63 39,75 -1,30% 1,70% 11.547.940
30/10/2001 40,31 40,60 39,91 40,28 -0,28% 1,72% 10.955.803
29/10/2001 40,34 40,83 40,33 40,39 -0,30% 1,25% 11.147.315
26/10/2001 40,15 40,74 39,98 40,51 -0,72% 1,89% 10.837.860
25/10/2001 39,90 40,88 39,56 40,81 +0,12% 3,31% 13.745.952
24/10/2001 40,40 41,03 40,23 40,76 +0,73% 2,00% 13.285.038
23/10/2001 40,71 40,78 40,04 40,46 -0,81% 1,82% 11.304.677
22/10/2001 40,07 40,80 40,04 40,80 +1,58% 1,89% 13.226.119
19/10/2001 39,66 40,16 39,57 40,16 +1,12% 1,48% 12.751.397
18/10/2001 39,37 40,04 39,37 39,72 +0,50% 1,69% 14.623.091
17/10/2001 39,37 39,83 39,14 39,52 +1,34% 1,76% 14.974.073
16/10/2001 39,56 39,71 38,54 38,99 -0,65% 2,95% 12.390.297
15/10/2001 38,80 39,67 38,78 39,25 +1,25% 2,30% 11.821.875
12/10/2001 38,33 38,99 38,28 38,77 +1,49% 1,86% 14.204.231
11/10/2001 39,42 39,51 38,19 38,20 -3,57% 3,35% 19.518.604
10/10/2001 38,65 39,77 38,43 39,61 +2,48% 3,46% 12.451.429
09/10/2001 38,84 38,88 38,39 38,65 -0,63% 1,27% 7.729.509
08/10/2001 39,52 39,60 38,75 38,90 -1,89% 2,16% 8.726.698
05/10/2001 38,92 39,80 38,88 39,65 +1,88% 2,36% 13.421.425